ArticleClinical and translational radiation oncology2020
Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer.
Hideya Yamazaki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.